Elias Fattal is a full professor of Pharmaceutical Technology at the University of Paris-XI in Châtenay-Malabry, France and has been President of APGI since 2003. He received his Pharmacy Degree (1983), and Ph.D. (1990) from the University of Paris-XI. After visiting the Department of Pharmaceutical Chemistry, University of California, San Francisco for a post-doctoral position with Frank Szoka (1990-1991), he became associate Professor (1992) and full Professor at the University of Paris-XI (2000). Elias Fattal is leading the research group “Drug targeting and delivery of poorly stable drugs” in the CNRS research unit UMR CNRS 8612. He is also vice-chair of this department. His research activity deals with the design of nano and microtechnologies for the delivery of peptides/proteins, nucleic acids and for imaging contrast agents. He is the author and co-author of around 150 publications and book chapters and 11 patents. In 1999, he received the Colloidal Drug Carrier Award (created for the 5th Expert meeting on colloidal drug carriers, Berlin, Germany) and the Pharmaceutical Sciences World Congress (PSWC) Research Achievement Award in 2007. He has also been elected Honour member of APV (Arbeitsgemeinschaft Pharmazeutische Verfahrenstechnik) in 2005. He is corresponding member of the French national Academy of Pharmacy. Elias Fattal is the co-editor of the journal of drug delivery science and technology. He serves in the editorial board of several Pharmaceutical Journals (Journal of Pharmaceutical Sciences, European Journal of Pharmaceutical Sciences, American Journal of Drug Delivery, and Expert Opinion on Drug Delivery) and nanotechnologies dedicated journals (NanoBiotechnology, International Journal of Nanomedecine).